Yixuan Gong Selected Research

Yixuan Gong Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 04/2006
7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 07/2012
7	Adenocarcinoma of Lung 05/2014 - 11/2006
6	Lung Neoplasms (Lung Cancer) 05/2014 - 08/2007
2	Carcinogenesis 11/2018 - 08/2007
2	Breast Neoplasms (Breast Cancer) 09/2015 - 05/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2009 - 07/2008
1	Hypoxia (Hypoxemia) 01/2022
1	Genomic Instability 01/2020
1	Inflammation (Inflammations) 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2018
1	Adenocarcinoma 05/2015
1	Neoplasm Metastasis (Metastasis) 06/2014
1	Fibrosis (Cirrhosis) 06/2014
1	Pathologic Processes 06/2014
1	Arthritis (Polyarthritis) 06/2014
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Urogenital Neoplasms 07/2012
1	Circulating Neoplastic Cells 07/2012
1	Disease Progression 10/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 08/2007
1	Hepatocellular Carcinoma (Hepatoma) 04/2006

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 11/2018 - 10/2009
6	Pharmaceutical PreparationsIBA 10/2015 - 08/2007
6	Phosphotransferases (Kinase)IBA 01/2013 - 11/2006
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2014 - 11/2006
3	Tissue Inhibitor of Metalloproteinase-1IBA 05/2015 - 01/2013
3	ErbB Receptors (EGF Receptor)IBA 07/2008 - 11/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2006
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 11/2019
2	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2018
2	AndrogensIBA 01/2018 - 05/2015
2	Androgen Receptors (Androgen Receptor)IBA 01/2018 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 05/2015 - 05/2014
2	Tyrosine Kinase InhibitorsIBA 01/2012 - 11/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2009 - 11/2006
2	3,3'-diindolylmethane (diindolylmethane)IBA 05/2006 - 04/2006
1	RNA (Ribonucleic Acid)IBA 01/2022
1	hydrogen sulfite (bisulfite)IBA 01/2022
1	SP_0782IBA 01/2020
1	Single-Stranded DNA (DNA, Single Stranded)IBA 01/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2019
1	cyclopropapyrroloindoleIBA 11/2019
1	CarcinogensIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 11/2018
1	Cisplatin (Platino)FDA LinkGeneric 11/2018
1	Phenobarbital (Luminal)FDA Link 11/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	NivolumabIBA 01/2018
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018
1	enzalutamideIBA 01/2018
1	Biological ProductsIBA 10/2015
1	2- dodecyl- 6- methoxycyclohexa- 2,5- diene- 1,4- dioneIBA 09/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015
1	Chromogranin AIBA 05/2015
1	EndopeptidasesIBA 06/2014
1	ZincIBA 06/2014
1	Matrix Metalloproteinases (MMPs)IBA 06/2014
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 06/2014
1	Matrix Metalloproteinase InhibitorsIBA 06/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2014
1	Small Interfering RNA (siRNA)IBA 05/2014
1	Neurofibromin 1 (Neurofibromin)IBA 05/2014
1	ras ProteinsIBA 05/2014
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2013
1	Monoclonal AntibodiesIBA 10/2009
1	teprotumumabIBA 10/2009
1	Antineoplastic Agents (Antineoplastics)IBA 10/2009
1	Cetuximab (Erbitux)FDA Link 10/2009
1	tyrosine receptor (receptor, tyrosine)IBA 10/2009
1	MAP Kinase Kinase 1IBA 07/2008
1	Lysine (L-Lysine)FDA Link 07/2008
1	Amino Acids FDA Link 07/2008
1	AsparagineIBA 07/2008
1	CaspasesIBA 10/2007
1	Methionine (L-Methionine)FDA Link 11/2006
1	Gefitinib (Iressa)FDA Link 11/2006
1	Threonine (L-Threonine)FDA Link 11/2006
1	Adenosine Triphosphate (ATP)IBA 05/2006

Therapy/Procedure

8	Therapeutics 01/2018 - 08/2007
5	Castration 01/2018 - 07/2012
1	Immunotherapy 11/2019
1	Drug Therapy (Chemotherapy) 11/2018
1	Precision Medicine 10/2015